Exclusive: Biomet picks BAML, Goldman, JPMorgan to lead IPO – sources

By Olivia Oran and Soyoung Kim NEW YORK (Reuters) – Biomet Inc, the U.S. medical device maker that was taken private by a private equity consortium for $11.4 billion in 2007, has hired underwriters for an initial public offering later this year, people familiar with the matter said on Wednesday. Biomet's owners — Blackstone Group LP , Goldman Sachs Group Inc's private equity arm, KKR & Co LP and TPG Capital LP — have selected Bank of America Merrill Lynch , Goldman Sachs Group and JPMorgan Chase & Co to lead the IPO, the people said.